Advancing Healthcare Through Innovation

Leading the future of pharmaceutical excellence with cutting-edge solutions

About Us

RIZ BIOSCIENCES delivers end-to-end pharma & specialty healthcare solutions, focused on Biopharma, rare disease & VAM therapeutics. Our mission is to transform patient care through innovative pharmaceutical development and strategic partnerships.

Services

Core Activities

Project Management

Licensing IN-OUT

Product Development

Business Areas

Oncological

Ophthalmic

Metabolic

Gynecology

R&D Technology Platform

Peptides

Nanotechnology

Liposomes

Monoclonal Antibodies MAB

Expansion Program

Global Presence

Our network spans 30+ countries across advanced and emerging markets, allowing us to support clients where science, regulation, and commercial opportunity intersect. We work closely with partners on the ground to adapt strategies to local regulatory environments, access dynamics, and competitive landscapes, while maintaining global quality and compliance standards. This reach enables us to connect innovators, manufacturers, and commercial organizations across continents and to help scale high‑value assets to diverse patient populations.

Current Projects & Investments

We are currently engaged in projects across APIs, biosimilars, complex generics, rare disease portfolios, and value‑added medicines, supporting clients from opportunity assessment through deal execution and market entry. Our work includes licensing and M&A mandates, CDMO and supply‑chain structuring, regulatory and GMP remediation, as well as strategic sourcing and portfolio optimization in both advanced and emerging markets. In parallel, we continue to invest in strengthening our global partner ecosystem and analytical capabilities so that clients can tap into specialized expertise quickly and scale their pipelines with confidence.